Edesa Biotech
EDSA | NASDAQ
$1.89
-$0.05 (-2.33%)
At close: Nov 16, 2026, 4:00 PM ET
$1.85
-$0.04 (-2.12%)
After-hours:
Nov 16, 2026, 7:57 PM ET
-2.33%
(1D)No price chart data available for 1D timeframe.
Rating
21.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #978/1021 (Top 96%)
Key Statistics
Market Data
Market Cap $18.21M
1D Range
1.73 2.00
52W Range
0.80 18.27
Valuation (TTM)
PE -1.12
PB 2.07
EV/EBITDA -0.55
Valuation (NTM)
Forward PE N/A
Forward PEG -0.29
Price Target $0.00
Cash Flow
FCF Yield -49.2%
SBC Adj. FCF Yield -51.4%
SBC Impact -4.5%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 14.9% |
47.9%
FCF 3Y | 5Y -25.3% |
0.0%
Returns
ROA -110.8%
ROE -124.2%
ROIC -166.0%
Financial Health
Net Cash
$10.33M
Current Ratio 2.76
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical opt...
Sector Healthcare
Industry Biotechnology
Employees 17
IPO Date Jun 21, 2010
Website www.edesabiotech.com
Fiscal Year October - September
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove EDSA